NCT00578916已完成1 期
Pharmacokinetics and Metabolism of [14C] BMS-690514 in Healthy Male Subjects
Bristol-Myers Squibb1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 17
- 试验地点
- 1
- 主要终点
- Single dose pharmacokinetics of BMS-690514 and radioactivity in plasma and urine
研究概览
简要总结
The purpose of this study is to determine how the human body processes and eliminates the drug (BMS-690514.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy male subjects
- •Body mass index (BMS) of 18 - 30 kg/m², inclusive
排除标准
- •Radiation exposure from diagnostic X-rays (except dental X-rays) in the last year or from clinical trials in the last 5 years
研究组 & 干预措施
1
Experimental
干预措施: EVRI (BMS-690514) (Drug)
结局指标
主要结局
Single dose pharmacokinetics of BMS-690514 and radioactivity in plasma and urine
时间窗: measured for 10 days post-dose
次要结局
- Determination of biotransformation profiles and recorded adverse events(for 10 days post-dose)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male ParticipantsHealthy VolunteersNCT04567667Bristol-Myers Squibb9
终止
1 期
A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced CancerCancerNCT00326131Bristol-Myers Squibb6
已完成
1 期
Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020Immunosuppression For DiseaseNCT02068053Bristol-Myers Squibb6
已完成
1 期
Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.HIV InfectionsNCT02206711ViiV Healthcare21
已完成
1 期
Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy VolunteersHealthyNCT02266550Boehringer Ingelheim6